SCHEMBL10698487

SCHEMBL10698487

Cc1ccc2cc(Cl)cc([N+](=O)[O-])c2n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 1/20 0.48
CTSH P09668 1/20 0.48
ALDH1A1 P00352 3/20 0.43
S1PR4 O95977 7/20 0.42
NFKBIA P25963 1/20 0.40
RELA Q04206 1/20 0.40
NPC1 O15118 2/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
KMT2A Q03164 1/20 0.40
HIF1A Q16665 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20838491 0.82 CTSB (0.49) CTSBCTSHALDH1A1S1PR4NFKBIA
SCHEMBL10622390 0.78 RELA (0.52) CTSBCTSHALDH1A1S1PR4NFKBIA
SCHEMBL20838507 0.77 NFKBIA (0.53) CTSBCTSHALDH1A1NFKBIARELA
SCHEMBL8548121 0.75 CTSB (0.60) CTSBCTSHALDH1A1NFKBIARELA
SCHEMBL20838508 0.75 CTSB (0.52) CTSBCTSHALDH1A1S1PR4NPC1
SCHEMBL10698059 0.75 MAPT (0.54) CTSBCTSHALDH1A1S1PR4RELA
SCHEMBL230859 0.75 RELA (0.59) CTSBCTSHALDH1A1NFKBIARELA
SCHEMBL10698493 0.74 ALDH1A1 (0.47) CTSBCTSHALDH1A1S1PR4NFKBIA
SCHEMBL3557626 0.74 HSP90AA1 (0.68) CTSBALDH1A1RELANPC1MAPT
SCHEMBL136263 0.73 CTSB (0.53) CTSBCTSHALDH1A1S1PR4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3466931-B1 TETRADENTATE CHELATING MONOQUINOLINE DERIVATIVE, MANUFACTURING METHOD THEREOF, AND APPLICATION OF SAME AS METAL ION REGULATOR FOR NEURODEGENERATIVE DISEASE UNIV GUANGDONG TECHNOLOGY (CN) 2024-01-10 EP disclosed
US-10807957-B2 Tetradentate chelating monoquinoline derivative, manufacturing method thereof, and application of same as metal ion regulator for neurodegenerative disease UNIV GUANGDONG TECHNOLOGY (CN) 2020-10-20 US disclosed
EP-3466931-A1 TETRADENTATE CHELATING MONOQUINOLINE DERIVATIVE, MANUFACTURING METHOD THEREOF, AND APPLICATION OF SAME AS METAL ION REGULATOR FOR NEURODEGENERATIVE DISEASE Guangdong University Of Technology (CN) 2019-04-10 EP disclosed
US-20190092730-A1 TETRADENTATE CHELATING MONOQUINOLINE DERIVATIVE, MANUFACTURING METHOD THEREOF, AND APPLICATION OF SAME AS METAL ION REGULATOR FOR NEURODEGENERATIVE DISEASE GUANGDONG UNIVERSITY OF TECHNOLOGY 2019-03-28 US disclosed
CN-105949120-A Four-tooth chelating single quinoline derivative, preparation method thereof and application as metal ion regulator for neurodegenerative disease 广东工业大学 2016-09-21 CN disclosed
EP-0282893-A2 Pesticides based on 1,10-phenanthrolines BAYER AG (DE) 1988-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10807957-B2 Tetradentate chelating monoquinoline derivative, manufacturing method thereof, and application of same as metal ion regulator for neurodegenerative disease SOD1, SLC30A6, SLC30A7 CTSB 2368/4885CTSH 3784/4885ALDH1A1 1013/4885
US-20190092730-A1 TETRADENTATE CHELATING MONOQUINOLINE DERIVATIVE, MANUFACTURING METHOD THEREOF, AND APPLICATION OF SAME AS METAL ION REGULATOR FOR NEURODEGENERATIVE DISEASE SOD1, SLC30A6, SLC30A7 CTSB 2368/4885CTSH 3784/4885ALDH1A1 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.